NCT03840096 is a NA clinical trial of Breg Flex in Knee Osteoarthritis, sponsored by The Hawkins Foundation.

Who is sponsoring NCT03840096?

NCT03840096 is sponsored by The Hawkins Foundation.

What drugs are being tested in NCT03840096?

Interventions in NCT03840096: Breg Flex.

What condition does NCT03840096 study?

NCT03840096 studies Knee Osteoarthritis.

Is NCT03840096 still recruiting?

NCT03840096 is currently completed. Last updated 9 September 2021.

Last reviewed 2021-09-09 · How we verify

NCT03840096

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of BREG Flex in 12-week Peri-operative Total Knee Arthroplasty

Completed NA Last updated 9 September 2021

What this trial tests

NA trial testing Breg Flex in Knee Osteoarthritis in 200 participants. Completed in 15 June 2021.

Timeline

1 June 2018

Primary endpoint
15 June 2021

15 June 2021

Quick facts

Lead sponsor	The Hawkins Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	1 June 2018
Primary completion	15 June 2021
Estimated completion	15 June 2021
Sites	2 locations across United States

Drugs / interventions tested

Breg Flex

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

The Hawkins Foundation

Who can join

55 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patient outcomes following total knee replacement and standard physical therapy will be compared between subjects who use the Breg Flex study device vs those who do not. Subjects will be evaluated for knee range of motion, strength and patient reported outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other The Hawkins Foundation trials

Trials by the same sponsor.

NCT03995290 — 3D Modeling to Improve Hip Arthroscopy Outcomes · terminated
NCT03961711 — Telemedicine in Total Hip Arthroplasty and Total Knee Arthroplasty · NA · completed
NCT02434913 — HUD: PIP Joint Implant · no longer available

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03840096 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hawkins Foundation
Last refreshed: 9 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03840096.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing